Humanin protected neurons, ovaries, and eyes in new studies

The first study looked at cultured neurons that had been pushed into senescence, a permanent stop in cell division that can make cells leak inflammatory factors ¹. Chronic treatment with HNG, a more potent form of Humanin with one amino acid change and roughly 1,000 times the cell-protection potency ⁴, reduced markers of this arrested state ¹.

The second study used a human ovarian granulosa cell line called KGN and rat ovary cultures ². Granulosa cells are the support cells around a developing egg. Adding Humanin outside the cells increased catalase activity, an antioxidant enzyme that breaks down hydrogen peroxide, and reduced programmed cell death after oxidative stress ².

The third study was in Royal College of Surgeons rats, a strain with inherited retinal degeneration ³. Twice-weekly HNG injection for up to four weeks did not change electroretinography, a measure of the retina's electrical response to light, but the high 4 mg/kg dose improved visual acuity on optokinetic testing, which measures how well the animal tracks moving stripes ³.

Study model	Stress or injury	Main finding
Mouse neurons and PC12 cells	Prolonged culture and glutamate	HNG reduced senescence markers and preserved dopamine release 1
KGN cells and rat ovary culture	Hydrogen peroxide	Humanin raised catalase and reduced programmed cell death 2
RCS rats	Inherited retinal degeneration	High-dose HNG improved visual acuity with no ERG change 3

The neuron study suggests Humanin does more than keep a cell alive. It also helps the cell keep releasing chemical messengers.

In the first experiment, mouse primary cortical neurons grown in culture for a long time began showing senescence markers, including a blue-staining enzyme and inflammatory secretions. HNG treatment reduced those markers over time ¹.

The researchers then used a model in which the brain chemical glutamate caused senescence in PC12 cells, a rat adrenal cell line that can behave like neurons. In that model, HNG lowered senescence markers and preserved the release of dopamine, a chemical messenger involved in movement and reward, after the cells were stimulated with acetylcholine, a nerve chemical ¹. The same cells also kept higher levels of synapsin 1 and synaptophysin, two proteins involved in the machinery that packages and releases chemical messengers ¹.

This fits earlier work showing that Humanin can protect neurons from amyloid-beta, a protein fragment linked to Alzheimer's, and from stroke damage ⁵. But those studies mostly looked at survival after an acute insult. The new work focuses on slower functional decline.

In ovarian tissue, Humanin protected the support cells that help decide whether a follicle survives under oxidative stress.

The KGN cells switched on more Humanin gene activity in response to hydrogen peroxide, which suggests the cells call on Humanin when stressed ². When researchers added Humanin from outside, catalase activity rose, meaning the cells could break down hydrogen peroxide more effectively. Superoxide dismutase, another antioxidant enzyme, did not change in expression or activity, so the effect was specific to catalase ².

The same study found fewer TUNEL-positive cells, a marker of programmed cell death, after Humanin treatment. Gene expression showed less BAX and caspase-3 precursor, two proteins that push cells toward death, with no change in BCL2, a protein that often opposes it ². In rat ovaries, Humanin also protected granulosa cells of antral follicles, the structures that hold developing eggs ².

The mechanism is consistent with Humanin's known ability to bind BAX before it can damage mitochondria ⁷. This is one of the most replicated actions in the field.

In the retina, high-dose HNG changed gene expression and improved vision even though electrical recordings stayed the same.

RCS rats received either 0.4 mg/kg or 4 mg/kg HNG twice a week starting at postnatal day 21. At four weeks, the high-dose group had significant improvement in visual acuity on optokinetic testing ³. Electroretinography showed no difference between either HNG dose and sham injection ³.

The high dose also produced the largest changes in genes related to programmed cell death, oxidative stress, inflammation, and retinal function ³. The study leaves open why the electrical recording did not match the behavioral result.

The three studies share a common theme. They test protection against slow oxidative damage rather than an acute injury.

That fits the known mechanism by which Humanin binds BAX and other cell-death proteins before they can damage mitochondria ⁷. The neuron study adds a functional layer: cells not only stayed alive but kept releasing dopamine, which matters for communication ¹. The ovarian study adds a tissue that had not received much attention in earlier Humanin research, though the mechanism matches the peptide's known BAX inhibition ². The retinal study shows a dose pattern: high-dose HNG improved visual acuity while electroretinography stayed the same in both dose groups ³.

Earlier rodent studies already reported that HNG reduced brain amyloid-beta and improved memory in an Alzheimer's model ⁵, and cut stroke damage ⁶. The new cell work sits comfortably inside that pattern, but it does not prove anything about human disease.

The data do not show that any of this translates to people. Two of the three studies were cell-culture experiments, and the rat study measured vision in an animal model of retinal degeneration ¹. No human randomized trial of Humanin or HNG has been completed ¹⁰.

The ovarian work used a cell line and rat ovary cultures, not live animals with a full hormonal environment ². The neuron study used differentiated PC12 cells, which are useful but not human neurons ¹. Dose and timing in people remain unknown. The retinal study also leaves open why electroretinography stayed flat even as visual acuity improved ³. In the research so far, Humanin keeps showing cell-level protection in stressed tissues, but the human evidence is still absent.